Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jorge Saucedo

Concepts (377)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angioplasty, Balloon, Coronary
40
2020
168
4.330
 Why?
Acute Coronary Syndrome
25
2020
106
4.130
 Why?
Myocardial Infarction
30
2017
449
3.720
 Why?
Platelet Aggregation Inhibitors
31
2020
211
3.610
 Why?
Registries
42
2020
638
2.590
 Why?
Percutaneous Coronary Intervention
20
2020
328
2.480
 Why?
Coronary Artery Disease
16
2020
323
2.010
 Why?
Stents
21
2020
368
1.950
 Why?
Ticlopidine
16
2016
71
1.630
 Why?
Risk Assessment
20
2019
1349
1.320
 Why?
Electrocardiography
11
2016
273
1.310
 Why?
Hospital Mortality
17
2020
451
1.220
 Why?
Hemorrhage
14
2018
225
1.200
 Why?
Coronary Angiography
19
2020
367
1.170
 Why?
Myocardial Revascularization
9
2017
29
1.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
12
2012
46
1.070
 Why?
Drug-Eluting Stents
7
2020
101
1.070
 Why?
Coronary Disease
13
2007
145
1.050
 Why?
Hirudins
7
2016
24
1.040
 Why?
Coronary Restenosis
7
2020
39
1.030
 Why?
Aged
74
2021
10242
0.990
 Why?
Anticoagulants
12
2015
276
0.970
 Why?
Peptide Fragments
7
2016
214
0.970
 Why?
Thiophenes
8
2014
45
0.950
 Why?
Time Factors
29
2020
2987
0.910
 Why?
Piperazines
8
2014
125
0.900
 Why?
Middle Aged
74
2020
13133
0.900
 Why?
Treatment Outcome
50
2021
5508
0.860
 Why?
Peptides
8
2010
239
0.860
 Why?
Purinergic P2Y Receptor Antagonists
6
2016
34
0.820
 Why?
Cardiac Catheterization
12
2021
228
0.810
 Why?
Male
85
2021
26874
0.800
 Why?
Platelet Aggregation
9
2014
76
0.800
 Why?
Sirolimus
5
2013
72
0.790
 Why?
Postoperative Complications
8
2020
1065
0.790
 Why?
Coronary Vessels
6
2017
169
0.780
 Why?
Myocardial Ischemia
7
2010
130
0.770
 Why?
Humans
112
2021
52441
0.750
 Why?
Coronary Artery Bypass
10
2015
135
0.750
 Why?
Female
82
2021
28277
0.740
 Why?
Guideline Adherence
6
2015
142
0.730
 Why?
Risk Factors
29
2020
3971
0.710
 Why?
Practice Guidelines as Topic
10
2015
498
0.660
 Why?
Heart Transplantation
4
2015
320
0.650
 Why?
Fibrinolytic Agents
5
2020
131
0.650
 Why?
Thrombosis
6
2014
250
0.630
 Why?
United States
27
2021
5215
0.620
 Why?
Drug Substitution
3
2014
13
0.610
 Why?
Retrospective Studies
27
2020
6694
0.590
 Why?
Follow-Up Studies
17
2019
2294
0.570
 Why?
Aged, 80 and over
24
2021
3449
0.540
 Why?
Myocardial Reperfusion
3
2015
13
0.540
 Why?
Saphenous Vein
2
2015
63
0.520
 Why?
Angina, Unstable
7
2006
25
0.510
 Why?
Cardiovascular Agents
3
2020
65
0.500
 Why?
Heparin, Low-Molecular-Weight
2
2016
21
0.500
 Why?
Renal Insufficiency, Chronic
3
2013
198
0.470
 Why?
Tyrosine
3
2004
97
0.470
 Why?
Immunosuppressive Agents
5
2013
248
0.460
 Why?
Coronary Sinus
1
2015
5
0.450
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2017
148
0.450
 Why?
Anastomosis, Surgical
1
2015
69
0.450
 Why?
Inpatients
3
2019
203
0.440
 Why?
Metals
2
2012
37
0.440
 Why?
Heart Valve Prosthesis
3
2021
89
0.430
 Why?
Patient Admission
1
2014
80
0.420
 Why?
Prospective Studies
16
2021
2433
0.420
 Why?
Heart Valve Prosthesis Implantation
3
2021
103
0.420
 Why?
Evidence-Based Medicine
7
2012
271
0.410
 Why?
Blood Platelets
6
2014
239
0.410
 Why?
Recombinant Proteins
8
2016
490
0.410
 Why?
Aspirin
7
2015
122
0.390
 Why?
Hemoglobins
1
2013
114
0.370
 Why?
Cardiology
3
2021
105
0.370
 Why?
Survival Rate
9
2017
944
0.370
 Why?
Diabetes Mellitus, Type 1
1
2014
217
0.360
 Why?
Severity of Illness Index
7
2018
1045
0.360
 Why?
Blood Vessel Prosthesis Implantation
2
2012
122
0.350
 Why?
Aorta
1
2012
170
0.350
 Why?
Mitral Valve
3
2020
57
0.350
 Why?
Aortic Aneurysm, Abdominal
1
2011
52
0.340
 Why?
Mitral Valve Annuloplasty
2
2021
6
0.340
 Why?
Diabetes Mellitus, Type 2
2
2014
570
0.330
 Why?
Mesenteric Artery, Superior
1
2010
10
0.320
 Why?
Ischemic Attack, Transient
2
2020
60
0.310
 Why?
Bioprosthesis
2
2021
40
0.310
 Why?
Angioplasty, Balloon
1
2010
68
0.310
 Why?
Thrombectomy
1
2010
74
0.300
 Why?
Prosthesis Design
6
2021
262
0.300
 Why?
Stroke
4
2020
527
0.300
 Why?
Patient Discharge
5
2018
320
0.300
 Why?
Kidney Diseases
1
2011
230
0.300
 Why?
Prosthesis Failure
2
2020
112
0.290
 Why?
Immunoglobulin Fab Fragments
3
2004
19
0.290
 Why?
Intracranial Hemorrhages
2
2019
43
0.290
 Why?
American Heart Association
2
2021
44
0.280
 Why?
Postoperative Hemorrhage
1
2008
54
0.280
 Why?
Chi-Square Distribution
6
2014
292
0.260
 Why?
Odds Ratio
6
2014
563
0.260
 Why?
Prognosis
9
2019
2100
0.260
 Why?
Stroke Volume
3
2019
148
0.250
 Why?
Antibodies, Monoclonal
4
2004
475
0.250
 Why?
Cardiovascular Diseases
2
2021
493
0.240
 Why?
Peripheral Arterial Disease
2
2019
78
0.240
 Why?
Internal Mammary-Coronary Artery Anastomosis
1
2005
5
0.230
 Why?
Mammary Arteries
1
2005
10
0.230
 Why?
Incidence
7
2019
1096
0.230
 Why?
Comorbidity
5
2015
637
0.230
 Why?
Ventricular Function, Left
2
2019
174
0.230
 Why?
Intermittent Claudication
3
2014
16
0.220
 Why?
Antithrombins
3
2016
22
0.220
 Why?
Heparin
1
2005
88
0.220
 Why?
Coronary Stenosis
1
2005
98
0.210
 Why?
Heart Valve Diseases
2
2020
55
0.210
 Why?
Platelet Function Tests
5
2014
21
0.200
 Why?
Vascular Diseases
2
2015
75
0.200
 Why?
Logistic Models
7
2014
930
0.200
 Why?
Administration, Oral
4
2013
455
0.200
 Why?
Shock, Cardiogenic
2
2018
35
0.200
 Why?
Aryl Hydrocarbon Hydroxylases
2
2013
75
0.200
 Why?
Double-Blind Method
7
2014
726
0.190
 Why?
Aortic Valve
2
2019
130
0.190
 Why?
Angiotensin Receptor Antagonists
2
2019
22
0.180
 Why?
Angiotensin-Converting Enzyme Inhibitors
2
2019
73
0.180
 Why?
Drug Therapy, Combination
5
2015
404
0.180
 Why?
Research Report
1
2021
19
0.170
 Why?
Receptors, Purinergic P2Y12
4
2013
17
0.170
 Why?
Recurrence
8
2018
680
0.170
 Why?
Adrenergic beta-Antagonists
2
2018
107
0.170
 Why?
Ethics, Medical
1
2021
44
0.170
 Why?
Patient Selection
7
2016
269
0.170
 Why?
Syndrome
6
2007
247
0.160
 Why?
Cardiac Catheters
1
2020
12
0.160
 Why?
Creatine Kinase
1
2000
31
0.160
 Why?
Hospitalization
7
2016
731
0.160
 Why?
Influenza, Human
1
2021
90
0.160
 Why?
Hemostatic Techniques
3
2009
31
0.160
 Why?
Angioplasty
1
2000
21
0.160
 Why?
Multivariate Analysis
7
2016
601
0.160
 Why?
Calcinosis
1
2020
48
0.160
 Why?
Renin-Angiotensin System
1
2019
58
0.150
 Why?
Cohort Studies
6
2018
1576
0.150
 Why?
Databases, Factual
4
2019
721
0.140
 Why?
Aortic Valve Stenosis
1
2019
79
0.140
 Why?
Cell Adhesion Molecules
3
2013
89
0.140
 Why?
Decision Support Techniques
1
2018
73
0.140
 Why?
Mitral Valve Insufficiency
1
2018
56
0.130
 Why?
Blood Coagulation
3
2014
64
0.130
 Why?
Graft Occlusion, Vascular
2
2012
78
0.130
 Why?
Adult
11
2015
14205
0.130
 Why?
Neoplasms
2
2017
1314
0.130
 Why?
Exercise Tolerance
2
2014
42
0.120
 Why?
Microfilament Proteins
2
2013
44
0.120
 Why?
Brachytherapy
3
2002
50
0.120
 Why?
Europe
4
2018
90
0.120
 Why?
Glomerular Filtration Rate
2
2013
126
0.120
 Why?
Radiography
4
2011
469
0.120
 Why?
Consensus
3
2021
195
0.120
 Why?
Research Design
2
2016
368
0.120
 Why?
Predictive Value of Tests
5
2018
938
0.120
 Why?
Troponin
2
2012
16
0.120
 Why?
Creatine Kinase, MB Form
2
2012
10
0.120
 Why?
Phosphoproteins
2
2013
123
0.120
 Why?
Heart Diseases
2
2012
217
0.110
 Why?
Vitamin K
1
2014
17
0.110
 Why?
Genotype
2
2014
563
0.110
 Why?
Holidays
1
2014
4
0.110
 Why?
Warfarin
1
2015
81
0.110
 Why?
Morbidity
1
2014
137
0.100
 Why?
Phenotype
2
2014
792
0.100
 Why?
Gene Transfer Techniques
2
2003
44
0.100
 Why?
Atrial Fibrillation
1
2015
196
0.100
 Why?
Drug Prescriptions
1
2013
112
0.100
 Why?
Statistics, Nonparametric
1
2013
199
0.100
 Why?
Aortography
1
2012
33
0.100
 Why?
Pharmacogenetics
1
2012
51
0.100
 Why?
Adenosine Monophosphate
1
2012
16
0.100
 Why?
Dose-Response Relationship, Drug
1
2016
1365
0.090
 Why?
Quinazolinones
1
2012
7
0.090
 Why?
Kidney Function Tests
1
2012
56
0.090
 Why?
Pyridines
1
2013
137
0.090
 Why?
Chronic Disease
2
2011
579
0.090
 Why?
Femoral Artery
3
2009
104
0.090
 Why?
Drug Delivery Systems
2
2005
148
0.090
 Why?
Propensity Score
3
2019
160
0.090
 Why?
Quality Indicators, Health Care
1
2012
91
0.090
 Why?
Bundle-Branch Block
1
2011
18
0.090
 Why?
Diabetes Complications
2
2002
124
0.090
 Why?
Emergency Service, Hospital
2
2013
521
0.090
 Why?
Aortic Rupture
1
2011
18
0.090
 Why?
Randomized Controlled Trials as Topic
5
2009
625
0.090
 Why?
Disease-Free Survival
5
2011
461
0.090
 Why?
Transportation of Patients
1
2011
39
0.090
 Why?
Sulfonamides
1
2012
137
0.090
 Why?
Hospitals
1
2012
182
0.090
 Why?
Diagnostic Imaging
1
2012
171
0.090
 Why?
Diabetic Angiopathies
1
2011
24
0.090
 Why?
Ischemia
1
2011
150
0.080
 Why?
Prevalence
4
2019
1016
0.080
 Why?
Feasibility Studies
1
2012
404
0.080
 Why?
Transplantation, Homologous
1
2011
151
0.080
 Why?
Algorithms
2
2008
673
0.080
 Why?
Patient Care Team
1
2012
267
0.080
 Why?
Graft Survival
1
2011
157
0.080
 Why?
Drug Administration Schedule
4
2014
370
0.080
 Why?
Health Services Accessibility
1
2014
444
0.080
 Why?
Fluoroscopy
1
2009
49
0.080
 Why?
Adolescent
3
2012
6713
0.080
 Why?
Clinical Trials as Topic
3
2008
461
0.080
 Why?
Genetic Vectors
2
2007
128
0.080
 Why?
Radiography, Interventional
1
2009
58
0.080
 Why?
Acute Disease
4
2014
384
0.080
 Why?
Endovascular Procedures
1
2011
180
0.070
 Why?
Palliative Care
1
2011
194
0.070
 Why?
Preoperative Care
2
2012
173
0.070
 Why?
Thrombelastography
1
2009
27
0.070
 Why?
Multicenter Studies as Topic
4
2017
112
0.070
 Why?
Emergency Treatment
1
2008
29
0.070
 Why?
Asia
2
2018
24
0.070
 Why?
Analysis of Variance
3
2009
558
0.070
 Why?
Age Factors
4
2018
1120
0.070
 Why?
Peripheral Vascular Diseases
1
2007
22
0.070
 Why?
Equipment Design
3
2020
287
0.070
 Why?
Plasmids
1
2007
162
0.060
 Why?
Kidney Failure, Chronic
1
2009
205
0.060
 Why?
International Cooperation
2
2016
52
0.060
 Why?
Thrombolytic Therapy
2
2004
113
0.060
 Why?
Young Adult
2
2012
4346
0.060
 Why?
Canada
2
2018
112
0.060
 Why?
Carrier Proteins
1
2007
312
0.060
 Why?
Coronary Vessel Anomalies
1
2005
37
0.060
 Why?
Iridium Radioisotopes
2
2002
5
0.060
 Why?
Quality of Health Care
1
2006
186
0.060
 Why?
Tennessee
1
2004
37
0.050
 Why?
Mississippi
1
2004
92
0.050
 Why?
Bradycardia
1
2004
37
0.050
 Why?
Infusions, Intravenous
1
2004
212
0.050
 Why?
Endothelial Growth Factors
1
2003
11
0.050
 Why?
Lymphokines
1
2003
20
0.050
 Why?
Oklahoma
2
2014
24
0.050
 Why?
Enoxaparin
1
2003
31
0.050
 Why?
Thrombocytopenia
1
2004
93
0.050
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
106
0.050
 Why?
Neovascularization, Physiologic
1
2003
86
0.050
 Why?
Coated Materials, Biocompatible
1
2002
34
0.050
 Why?
Point-of-Care Systems
1
2003
68
0.050
 Why?
Paclitaxel
1
2002
91
0.050
 Why?
Platelet Activation
2
2013
46
0.050
 Why?
Thalidomide
1
2004
376
0.050
 Why?
Diabetes Mellitus
2
2002
318
0.050
 Why?
Tissue Adhesives
1
2001
15
0.050
 Why?
Latin America
1
2021
10
0.040
 Why?
Cell Cycle
1
2002
236
0.040
 Why?
Angioplasty, Laser
1
2001
1
0.040
 Why?
Heptanoic Acids
1
2000
35
0.040
 Why?
Anticholesteremic Agents
1
2000
31
0.040
 Why?
Punctures
3
2009
50
0.040
 Why?
Pulmonary Edema
1
2000
15
0.040
 Why?
Walking
2
2014
105
0.040
 Why?
Quality of Life
2
2007
893
0.040
 Why?
Pyrroles
1
2000
73
0.040
 Why?
Regression Analysis
2
2016
400
0.040
 Why?
Yttrium Radioisotopes
1
2000
10
0.040
 Why?
Atherectomy, Coronary
1
1999
5
0.040
 Why?
Arterial Occlusive Diseases
1
1999
80
0.040
 Why?
Vaccination
1
2021
294
0.040
 Why?
Cause of Death
1
2019
157
0.040
 Why?
Tissue Plasminogen Activator
1
1999
108
0.040
 Why?
Gender Identity
1
2018
25
0.040
 Why?
Arkansas
1
2004
2013
0.040
 Why?
Brazil
1
2018
39
0.040
 Why?
Intra-Aortic Balloon Pumping
1
2018
6
0.040
 Why?
Echocardiography, Doppler, Color
1
2018
21
0.040
 Why?
Length of Stay
1
2001
673
0.040
 Why?
Sweden
1
2018
11
0.040
 Why?
Hypolipidemic Agents
1
1998
30
0.040
 Why?
Erythrocyte Transfusion
1
2018
52
0.030
 Why?
Administration, Intravenous
1
2018
73
0.030
 Why?
Echocardiography, Transesophageal
1
2018
60
0.030
 Why?
South America
1
2017
4
0.030
 Why?
Cardiotonic Agents
1
2018
70
0.030
 Why?
North America
1
2017
75
0.030
 Why?
Recovery of Function
1
2018
201
0.030
 Why?
Methods
1
1996
53
0.030
 Why?
Equipment and Supplies
1
1996
16
0.030
 Why?
Hemodynamics
1
2018
235
0.030
 Why?
Internationality
1
2016
46
0.030
 Why?
Patient Readmission
1
2018
249
0.030
 Why?
Blood Transfusion
1
2016
126
0.030
 Why?
Intraoperative Complications
1
1996
113
0.030
 Why?
International Normalized Ratio
1
2014
29
0.030
 Why?
Ankle Brachial Index
1
2014
15
0.030
 Why?
Mobility Limitation
1
2014
27
0.030
 Why?
Animals
4
2002
13485
0.030
 Why?
Drug Resistance
1
2014
69
0.030
 Why?
Blood Pressure
2
2007
525
0.030
 Why?
Aryldialkylphosphatase
1
2013
6
0.030
 Why?
Sex Factors
2
2009
735
0.030
 Why?
Biotransformation
1
2013
83
0.030
 Why?
Exercise Test
1
2014
134
0.030
 Why?
Oxygen Consumption
1
2014
193
0.020
 Why?
Polymorphism, Genetic
1
2013
184
0.020
 Why?
Adrenergic beta-1 Receptor Antagonists
1
2012
7
0.020
 Why?
Alleles
1
2013
279
0.020
 Why?
Child
1
2005
7194
0.020
 Why?
Drug Antagonism
1
2012
8
0.020
 Why?
Embolic Protection Devices
1
2012
7
0.020
 Why?
Critical Pathways
1
2012
36
0.020
 Why?
Injections, Intravenous
1
2012
130
0.020
 Why?
Secondary Prevention
1
2012
85
0.020
 Why?
Natriuretic Peptide, Brain
1
2011
32
0.020
 Why?
Models, Statistical
1
2012
230
0.020
 Why?
Kaplan-Meier Estimate
1
2011
485
0.020
 Why?
Cross-Over Studies
1
2011
236
0.020
 Why?
Cells, Cultured
1
2013
1583
0.020
 Why?
Multiple Myeloma
1
2004
3013
0.020
 Why?
Femur Head
1
2009
26
0.020
 Why?
Probability
2
2001
171
0.020
 Why?
Confidence Intervals
1
2009
158
0.020
 Why?
Area Under Curve
1
2009
182
0.020
 Why?
Hemorheology
1
2009
6
0.020
 Why?
Receptors, Thrombin
1
2009
14
0.020
 Why?
Adenosine Diphosphate
1
2009
22
0.020
 Why?
Polysaccharides
1
2009
58
0.020
 Why?
Linear Models
1
2009
288
0.020
 Why?
Cross-Sectional Studies
1
2014
1677
0.020
 Why?
Patient Education as Topic
1
2011
317
0.020
 Why?
Collagen
1
2009
215
0.020
 Why?
Ankle
1
2007
15
0.020
 Why?
Brachial Artery
1
2007
17
0.020
 Why?
Injections, Intramuscular
1
2007
57
0.020
 Why?
Calcium-Binding Proteins
1
2007
59
0.020
 Why?
Disease Progression
1
2010
870
0.020
 Why?
Heart Conduction System
1
2006
24
0.020
 Why?
Combined Modality Therapy
2
1999
641
0.020
 Why?
Sex Distribution
1
2006
138
0.020
 Why?
Age Distribution
1
2006
176
0.020
 Why?
Body Mass Index
1
2009
701
0.020
 Why?
Genetic Therapy
1
2007
127
0.020
 Why?
Insurance, Health
1
2006
132
0.010
 Why?
Ultrasonography, Interventional
1
2006
137
0.010
 Why?
Societies, Medical
1
2005
200
0.010
 Why?
Platelet Adhesiveness
1
2004
14
0.010
 Why?
Abnormalities, Multiple
1
2005
164
0.010
 Why?
Platelet Count
1
2004
78
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Adenoviridae
1
2003
46
0.010
 Why?
Injections, Subcutaneous
1
2003
54
0.010
 Why?
Smoking
1
2006
514
0.010
 Why?
Endpoint Determination
1
2002
27
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2003
186
0.010
 Why?
Echocardiography
1
2005
409
0.010
 Why?
Instillation, Drug
1
2002
2
0.010
 Why?
Catheters, Indwelling
1
2001
56
0.010
 Why?
Angina Pectoris
1
2001
19
0.010
 Why?
Survival Analysis
1
2002
656
0.010
 Why?
Hypoglycemic Agents
1
2002
223
0.010
 Why?
District of Columbia
1
2000
20
0.010
 Why?
Insulin
1
2002
485
0.010
 Why?
Tunica Intima
1
2000
55
0.010
 Why?
Cineangiography
1
1999
9
0.010
 Why?
Partial Thromboplastin Time
1
1999
14
0.010
 Why?
Prothrombin Time
1
1999
18
0.010
 Why?
United States Food and Drug Administration
1
1999
89
0.010
 Why?
Radiographic Image Enhancement
1
1999
30
0.010
 Why?
Coronary Thrombosis
1
1999
22
0.010
 Why?
Coronary Circulation
1
1999
57
0.010
 Why?
Regional Blood Flow
1
1999
109
0.010
 Why?
Dogs
1
1999
183
0.010
 Why?
Radiotherapy, Adjuvant
1
1999
65
0.010
 Why?
Safety
1
1999
78
0.010
 Why?
Swine
1
2000
428
0.010
 Why?
Sensitivity and Specificity
1
2000
871
0.010
 Why?
Postoperative Care
1
1998
104
0.010
 Why?
Lipids
1
1998
163
0.010
 Why?
Disease Models, Animal
1
1999
1483
0.010
 Why?
Mice
1
1999
5899
0.000
 Why?
Saucedo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (377) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department